BIOL News and Press, Biolase Inc. From 12/12/23

BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial PR Newswire Receives Overwhelmingly Positive Dentist Feedback and Unanimous Approval During Independently led Trial Results Demonstrate 100% Performance Satisfaction and Recommendation of Wider Adopt...

BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire LAKE FOREST, Calif. , Dec. 6, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today tha...

2023-12-06 10:00:30 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Biocryst Pharm...

2023-12-06 08:38:42 ET More on pre-market losers and stocks. NeuroSense: A Hold Ahead Of Phase 2b ALS Data NeuroSense ALS candidate meets key study goals Janover inks strategic referral partnership with La Rosa Holdings Seeking Alpha’s Quant Rating on ...

2023-11-10 10:00:06 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employ...

2023-11-09 16:39:02 ET More on Biolase BIOLASE down 30%, prices $4.5M stock offering Seeking Alpha’s Quant Rating on Biolase Historical earnings data for Biolase Financial information for Biolase For further details see: Biolase GAAP EPS of...

BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES PR Newswire LAKE FOREST, Calif. , Nov. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the g...

2023-11-09 08:36:55 ET Losers: Atara Biotherapeutics ATRA -58% falls 50% after-hours on failed Phase 2 study for MS drug. Assertio Holdings ASRT -46% after Q3 earning release . Cardlytics CDLX -36% after Q3 earning release . Inspired Entertainment (...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR® Perio Protocol PR Newswire Validates BIOLASE REPAIR ® Perio Protocol is a Superior Alternative as it pertains to patie...